ATHEROSCLEROTIC CARDIOVASCULAR DISEASE (ASCVD)
Clinical trials for ATHEROSCLEROTIC CARDIOVASCULAR DISEASE (ASCVD) explained in plain language.
Never miss a new study
Get alerted when new ATHEROSCLEROTIC CARDIOVASCULAR DISEASE (ASCVD) trials appear
Sign up with your email to follow new studies for ATHEROSCLEROTIC CARDIOVASCULAR DISEASE (ASCVD), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Major heart study tests new drug to stop deadly cardiac events
Disease control OngoingThis large, late-stage study is testing whether an investigational drug called lepodisiran can reduce the risk of major heart problems like heart attacks, strokes, and heart-related death. It involves over 17,000 adults who have high levels of a specific blood fat (lipoprotein(a)…
Matched conditions: ATHEROSCLEROTIC CARDIOVASCULAR DISEASE (ASCVD)
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Apr 02, 2026 09:27 UTC
-
Major 5-Year trial tests if new drug can shield hearts and kidneys
Disease control OngoingThis large, late-stage study aims to see if the medication retatrutide can lower the risk of serious heart problems like heart attacks and strokes, and slow the worsening of kidney disease. It will involve 10,000 adults who are overweight or obese and already have heart disease a…
Matched conditions: ATHEROSCLEROTIC CARDIOVASCULAR DISEASE (ASCVD)
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC